May 2, 2023 8:30am EDT Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
Apr 25, 2023 8:00am EDT Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs